Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Researchers found specific genes in the part of hair follicles that could help treat hair disorders.

Hair loss can be treated with common methods like minoxidil and finasteride, but new potential treatments include growth factors, cytokines, and platelet-rich plasma injections.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Blocking the mineralocorticoid receptor can help treat skin thinning caused by steroids.

Mitochondrial problems in diabetic nerve damage might cause pain by lowering the production of certain nerve-related steroids.

Sp6 promotes tooth development by reducing follistatin levels.

Stress stops hair growth in mice by causing early hair growth phase end and harmful inflammation through a specific nerve-related pathway.

The mouse models are effective for testing new hair loss treatments.

Schizophrenia risk genes may affect early brain development, contributing to the disease.

The TRPV3 ion channel is important for skin and hair health and could be a target for treating skin conditions.

Finasteride may cause floppy-iris syndrome during cataract surgery, so check patients' medical history.

CLE40 and CRN/CLV2 pathways have opposite effects on root growth in Arabidopsis.

Individualized treatment plans, including lifestyle changes and specific medications, are crucial for managing PCOS in adolescents.

Scalp psoriasis features reversible hair loss and specific immune activation, with no significant hair follicle damage.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

The conclusion suggests that treatments targeting root causes of chronic diseases may be developed by focusing on gene expression and lifestyle factors.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Leptin helps start the growth phase of hair.

CRTH2 antagonists might be useful for treating many conditions because they play a role in immune and inflammation responses.

Methotrexate treats various disorders by inhibiting DNA synthesis, but careful monitoring is needed to avoid toxicity and manage side effects.

Blocking TRPV3 may help treat itch in dry skin conditions.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Metformin helps reduce PCOS-related infertility by improving insulin sensitivity and inducing ovulation.

Targeting the PGD2-DP2 pathway may help treat hair loss.